Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease
Author(s) -
Vikram S. Kashyap,
Peter A. Schneider,
Mazin I. Foteh,
Raghu L. Motaganahalli,
Rasesh Shah,
HansHenning Eckstein,
Steve Henao,
Glenn M. LaMuraglia,
Michael C. Stoner,
Jim Melton,
Douglas W. Massop,
Tod Hanover,
Jessica Titus,
Wesley S. Moore,
Rubén Rodríguez-Carvajal,
Mahmoud B. Malas,
Frank R. Arko,
Damon S. Pierce,
Paul Anain,
Timothy C. Oskin
Publication year - 2020
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.120.030550
Subject(s) - medicine , stroke (engine) , carotid endarterectomy , asymptomatic , clinical endpoint , population , carotid artery disease , stenosis , revascularization , surgery , myocardial infarction , cardiology , randomized controlled trial , mechanical engineering , environmental health , engineering
Transcarotid artery revascularization (TCAR) is comprised of carotid artery stent placement with cerebral protection via proximal carotid artery clamping and reversal of cerebral arterial flow. The aim of the present study was to evaluate the safety and efficacy of TCAR performed by a broad group of physicians with variable TCAR experience.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom